Header cover image

Danish Healthcare Undervalued over 20% based on DCF

Results

4

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

4 companies

Coloplast

Market Cap: DKK 96.8b

Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.

COLO B

DKK 429.80

7D

1.1%

1Y

-38.8%

Demant

Market Cap: DKK 44.6b

Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally.

DEMANT

DKK 211.60

7D

11.7%

1Y

-6.9%

Ambu

Market Cap: DKK 17.7b

Researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally.

AMBU B

DKK 66.85

7D

3.6%

1Y

-43.3%

Embla Medical hf

Market Cap: DKK 11.6b

Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

EMBLA

DKK 27.25

7D

3.2%

1Y

1.5%